Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.729
-4.07 %
$ 21 M
Market Cap
-0.81
P/E
CYTH - STOCK-BASED COMPENSATION
Stock-based Compensation CYTH - Cyclo Therapeutics, Inc.
737 K
LAST VALUE
25.10%
2 YEAR CAGR
54.61%
5 YEAR CAGR
33.82%
10 YEAR CAGR